Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ASBP: Aspire Biopharma Holdings, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ASBP
The Story
ASBP
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
-15745.9%
ROIC
-99.6%
Financially safe
Stretched
Debt / equity
0.39×
Interest coverage
-0.6×
Current ratio
2.26×
Aspire Biopharma Holdings, Inc.
ASBP
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Aspire Biopharma Holdings, Inc.
ASBP
NASDAQ
·
USD
·
Closed
$6.52
−2.98%
$6.52
−$0.20 (2.98%)
52W Range
18th
pctl
Volume
0.00×
avg
Mkt Cap
752225
USD
P/E
-0.8
TTM
Div Yield
–
ann
52W Range
18th
pctl
Volume
0.00×
avg
Market Cap
752225
USD
P/E Ratio
-0.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings